Coronavirus Info Center

News & Resources to Support Your Supply Chain

Coronavirus (COVID-19)
Quick Information Center

The coronavirus outbreak is a constantly evolving situation, and The Quick Group is committed to staying in close communication with our customers during this health crisis. This page is designed to provide you with the latest information and answers to your questions regarding how the outbreak is impacting global shipments. We’re also including links to relevant information published by expert sources. If you have questions or need information that is not addressed on this page, please contact your local customer service office or your Quick/Sterling representative.

In the meantime, we remain focused on continuing to deliver the transportation solutions that meet your urgent shipping needs.

Latest News - VACCINE UPDATES
J&J COVID-19 vaccine authorized for use in the United States

J&J COVID-19 vaccine authorized for use in the United States

28 Feb, 2021 - VACCINE UPDATES - North America
Late Saturday, the FDA granted emergency use authorization to Johnson & Johnson's single-dose coronavirus vaccine. The J&J vaccine is the 3rd to receive the authorization—which will help speed up the vaccine rollout across the United States.
www.cnbc.com

FDA staff endorses Johnson & Johnson single-shot COVID vaccine for emergency use.

24 Feb, 2021 - VACCINE UPDATES - North America, EMEA, LATAM, APAC
If approved, J&J’s application would be the 3rd vaccine authorized for emergency use in the United States—following those developed by Pfizer-BioNTech & Moderna www.washingtonpost.com

Pfizer Coronavirus Vaccine Protects Against U.K., South Africa Variants, Study Shows

20 Feb, 2021 - VACCINE UPDATES - North America, EMEA, LATAM, APAC
The vaccine developed by Pfizer appears to be effective against the more transmissible variants of the coronavirus, including the one first discovered in South Africa www.usnews.com

The vaccine developed by the University of Oxford & AstraZeneca not only protects people from serious illness & death, it also slows the transmission of the virus.

03 Feb, 2021 - VACCINE UPDATES - North America, EMEA, LATAM

The researchers' study is the first to demonstrate evidence that any coronavirus vaccine can reduce virus transmission.

Read more: www.cnn.com

Johnson & Johnson announced today that their one-shot vaccine protects against COVID-19, but it is not as strong as others already being used in the U.S.

29 Jan, 2021 - VACCINE UPDATES - North America, EMEA, LATAM, APAC
The company said that trials in the U.S. & seven other countries showed 66% effectiveness in preventing moderate to severe illness and was 85% protective against the most serious symptoms. www. cnn.com

Biotech firm, Novavax, said today that its COVID-19 vaccine is 89 percent effective.

28 Jan, 2021 - VACCINE UPDATES - North America, EMEA, LATAM, APAC
However, a separate phase two study in South Africa showed that the vaccine isn’t nearly as effective against a new strain that has been ravaging the country. Read more
Page #1 (1-6 of 17)
Resources

What to do after being vaccinated

17 Feb, 2021 - Helpful Links
If you are wondering when immunity kicks in and how long it will last after receiving the vaccine, watch this World Health Organization video, "I'm vaccinated, What's Next?" www.who.int
9 Ways the Pandemic Will Change Travel in 2021

9 Ways the Pandemic Will Change Travel in 2021

17 Feb, 2021 - Helpful Links
Workcations" or "flexcations" could be the new travel trend for 2021—a trip combining remote working and travel with family and friends. If you see a "workcation" in your future, you'll want to check out the answers to 9 of the most pressing travel queries. www.nytimes.com
The Quick Group’s IT Roundtable: Managing a Crisis on the Global Stage

The Quick Group’s IT Roundtable: Managing a Crisis on the Global Stage

17 Feb, 2021 - Podcasts & eBooks
Listen to The Quick Group's IT leaders discussion on business continuity & supporting customers' mission-critical logistics during a global pandemic. View video
"COVID-19 Speeds Adoption of Direct-to-Patient and Virtual Clinical Trials."

"COVID-19 Speeds Adoption of Direct-to-Patient and Virtual Clinical Trials."

17 Feb, 2021 - Ask the Experts
QuickSTAT's Scott Ohanesian discusses the need to quickly move to a Direct-to-Patient (DTP) model once COVID-19 shut down borders. Read more
Did you know that the age to donate ranges from 17 to 66?

Did you know that the age to donate ranges from 17 to 66?

26 Jan, 2021
As long as you meet the donation criteria, a fit and healthy person should be able to donate blood several times a year. www.redcross.org
Back to the Listing Page
Menu